An inquest held at Oxfordshire Coroner’s Court on April 15 has determined that an Oxfordshire man’s death was caused by a combination of amisulpride and cocaine.

The hearing examined the death of Benjamin Mander, whose passing was attributed to the toxic effects of these substances, leading to a brain injury resulting from oxygen deprivation.

Amisulpride, marketed under the brand names Socian and Barhemsys, serves as a treatment for schizophrenia, depression, as well as nausea and vomiting.

When the brain experiences insufficient oxygen, this results in a hypoxic brain injury.

Mr Mander passed away on November 9, 2025, at age 45. His birth occurred on March 11, 1980, in Salford, Manchester.

A resident of Witney, he worked as a healthcare assistant and had previously experienced mental health difficulties alongside problems with substance use.

Emergency services were called to his residence in the early hours of November 9 after he was found convulsing. He was transported to the John Radcliffe Hospital where he subsequently died.

The coroner’s official summary reported that Benjamin Mander had experienced mental health conditions and problems with both drugs and alcohol.

He was found unresponsive and experiencing a seizure at his residence just after midnight on November 9, 2025.

The toxic effects of amisulpride and cocaine are believed to have caused the incident, resulting in a hypoxic brain injury.

Paramedics transported him by ambulance to the John Radcliffe Hospital, where he died later that same day.

Senior coroner Darren Michael Salster presided over the inquest and determined the death was related to drugs.